ConductScience.org, home

Gene · 1908

NIH grants1,222

NIH grants whose papers are about the gene, through NIH's grant-paper links.

261 to 280 of 1,222

Download this page as JSON
GrantTitleEDN3 papersNewest fiscal year
U24CA180922Trinity: Transcriptome assembly for genetic and functional analysis of cancer12022
U24DC015910The Human Temporal Bone Laboratory Resource for Basic and Applied Inner Ear Sciences12022
U24DK116195Illuminating the Druggable GPCR-ome12022
R01DK044628TLR4 in the Regulation of Renal Microvascular Function42021
T32GM008602Graduate Training in the Pharmacological Sciences42021
F30CA220954Dissecting the Ecology of Metastasis in a Zebrafish Model: Trade-Offs of Size and Diversity in Circulating Tumor Cell Clusters32021
R01HL141781Approach for in vivo gene delivery into hematopoietic stem cells for hemophilia A therapy32021
U01DK062370Identifying Genes for Type 2 Diabetes: FUSION32021
R01DC015785Role of endothelin signaling in the development of intermediate cells in the stria vascularis22021
R01GM125322Tissue mechanics in regenerative wound healing of the skin22021
T32GM007365Medical Scientist Training Program22021
U01HG009716Hearing Impairment Genetics Studies in Africa (HI-GENES Africa)22021
F30GM131672Contributions of Gα Subunit Distal Helix 5 to GPCR-G Protein Selectivity12021
F32MH116590Probing schizophrenia associated neurodevelopmental defects in integrated neocortical organoids12021
K08DK110532Enteric Glia, Sexual Dimorphism and GI Motility12021
K08HG008986Individual genomic analyses to discover the molecular basis and mechanisms contributing to adult-onset disease12021
R01AG056352Impaired Gait in Older Adults: Pathologies of Alzheimer's disease and Related Disorders12021
R01AR071439Targeting Dystroglycanopathies using Pluripotent-derived Myogenic Progenitors12021
R01AR072638Regeneration and Differentiation Potential of Heterogeneous Human Satellite Cells12021
R01CA212662Exploiting vulnerabilities in GIST using novel combination therapies12021

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1908/grants?page=14